Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
20.15
+0.36 (1.79%)
Nov 21, 2024, 2:24 PM EST - Market open
Viridian Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$37.25
Upside
+84.91%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $27 → $34 | Strong Buy | Maintains | $27 → $34 | +68.78% | Nov 14, 2024 |
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +88.63% | Nov 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +88.63% | Oct 28, 2024 |
| BTIG | BTIG | Strong Buy Maintains $56 → $61 | Strong Buy | Maintains | $56 → $61 | +202.80% | Sep 26, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $44 | Buy | Reiterates | $44 | +118.42% | Sep 19, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $35 → $44 | Buy | Maintains | $35 → $44 | +118.42% | Sep 13, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $25 → $31 | Strong Buy | Maintains | $25 → $31 | +53.88% | Sep 12, 2024 |
| Needham | Needham | Strong Buy Maintains $30 → $38 | Strong Buy | Maintains | $30 → $38 | +88.63% | Sep 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $27 | Strong Buy | Reiterates | $27 | +34.03% | Sep 10, 2024 |
| BTIG | BTIG | Strong Buy Maintains $46 → $56 | Strong Buy | Maintains | $46 → $56 | +177.98% | Sep 10, 2024 |
| Needham | Needham | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +48.92% | Aug 30, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $35 | Buy | Reiterates | $35 | +73.74% | Aug 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $27 | Strong Buy | Reiterates | $27 | +34.03% | Aug 15, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $31 → $28 | Buy | Reiterates | $31 → $28 | +38.99% | Aug 12, 2024 |
| Wedbush | Wedbush | Buy Reiterates $42 | Buy | Reiterates | $42 | +108.49% | Jul 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $27 | Strong Buy | Reiterates | $27 | +34.03% | Jul 16, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.